Therapeutics Japan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutics japan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutics Japan Today - Breaking & Trending Today

VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

Yutaka Iijima , Hayami Masanori , Robertg Hisaoka , Sachiko Kuno , Wataru Akahata , Ryuji Ueno , Vaccine Research Center , Global Communications , National Institutes Of Health , Sk Impact Fund , Capital Co Ltd , Sojitz Corporation , Tokyo Institute Of Technology , Bank Ltd , Therapeutics Japan , Kyoto University Graduate School Of Medicine , Kyoto University Institute For Virus Research , Therapeutics Inc , University Of Tokyo , Nobelpharma Co Ltd , Kyoto University Graduate School Of Human , Kyoto University , Graduate School , Kyoto University Institute , National Institutes , Nature Medicine ,

VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D

/PRNewswire/ US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on December 27 that it has signed an agreement for an investment of US$21. ....

Yutaka Iijima , Hayami Masanori , Sachiko Kuno , Wataru Akahata , Ryuji Ueno , Vaccine Research Center , Global Communications , National Institutes Of Health , Tokyo Institute Of Technology , Kyoto University Graduate School Of Medicine , Therapeutics Japan , Therapeutics Inc , Kyoto University Institute For Virus Research , University Of Tokyo , Kyoto University Graduate School Of Human , Kyoto University , Graduate School , Kyoto University Institute , National Institutes , Nature Medicine , Tokyo Institute , Kyoto University Graduate School , Vlp Therapeutics ,

Japanese vaccine using smaller dose than Pfizer, Moderna in trials | The Asahi Shimbun: Breaking News, Japan News and Analysis

A Japanese drug development venture firm has launched the first phase of a clinical trial for a new type of COVID-19 vaccine that can induce sufficient immunity using smaller dosages than existing vaccines. ....

Wataru Akahata , National Center , Oita University , Fujifilm Corp , Us National Institutes Of Health , Osaka City University , Therapeutics Japan , Global Health , Sci Tech , Asahi Shimbun ,

Japan biotech startup pushes for mRNA shot suited for mass production

The key benefit of self-replicating vaccines is their efficiency, as they require only a fraction of the dosage of conventional vaccines to trigger a strong immune response. ....

Japan General , South Africa , Tetsuo Nakayama , Wataru Akahata , Fujifilm Corp , Us National Institutes Of Health , Kitasato Institute For Life Sciences , National Institute Of Biomedical Innovation , Osaka City University , Moderna Inc , Japan Agency For Medical Research , U Pfizer Inc , Oita University Hospital In Kyushu , National Center , Oita University , Elixirgen Therapeutics Inc , Hokkaido University , Fujita Health University In Aichi Prefecture , Therapeutics Japan , San Arcturus Therapeutics Holdings Inc , Global Health , Nagoya Medical Center , Japanese Society Of Clinical Virology , Oita University Hospital , National Institute , Biomedical Innovation ,

VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D

Press release content from PR Newswire. The AP news staff was not involved in its creation.
VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D
March 15, 2021 GMT
Logo of VLP Therapeutics
GAITHERSBURG, Md., March 15, 2021 /PRNewswire/ US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on March 15 that it has raised US$16 million in a Series A funding round from MIYAKO Capital Co., Ltd., Sojitz Corporation, Konishiyasu Co., Ltd., in Japan and three existing investors in the US (Mr. Robert G. Hisaoka, SK Impact Fund, LLC, and RJ Fund, LLC) for research and development of a cancer treatment vaccine. With this funding, VLPT aims to accelerate the project well underway in the US and move into clinical trials at the earliest date possible. ....

Robertg Hisaoka , Hiroyuki Misawa , Wataru Akahata , Yutaka Iijima , Masayoshi Fujimoto , Hayami Masanori , Sachiko Kuno , Toshiyuki Konishi , Ryuji Ueno , Global Communications , Sk Impact Fund , Sojitz Corporation , Fujifilm Corporation , Therapeutics Inc , Konishiyasu Co Ltd , Japan Agency For Medical Research , Vaccine Research Center , National Institutes Of Health , Capital Co Ltd , Rj Fund , Tokyo Institute Of Technology , Kyoto University Graduate School Of Medicine , Therapeutics Japan , Kyoto University Institute For Virus Research , University Of Tokyo , Kyoto University Graduate School Of Human ,